Press Release: Alamar Biosciences : Sapient Partners with Alamar Biosciences to Extend Targeted Proteomics Services Using NULISA Assays for Cytokines, Chemokines, and Inflammatory Mediators

SAN DIEGO--(BUSINESS WIRE)-- #chemokineassays--Sapient, a leader in multi-omics discovery, has partnered with Alamar Biosciences, a pioneer in ultra-sensitive and highly multiplexed immunoassay technologies, to extend its targeted proteomics services to include high-sensitivity cytokine, chemokine, and neuroinflammatory mediator multiplex and single-plex assays using Alamar's NULISA platform and ARGO® HT system. Sapient will be an Alamar certified service provider for the NULISAseq Inflammation Panel profiling